MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Gastroenterology

Disrupted Microbial Metabolism in Gut Inflammation as a Key Driver of Adverse Food Reactions in IBD

MedXY Editorial Team•Oct 13, 2026•Gastroenterology
food sensitizationgut inflammationinflammatory bowel diseasemicrobiota

Highlight

  • Intestinal inflammation disrupts gut microbial metabolism of food antigens, facilitating food sensitization.
  • Inflammation-driven depletion of specific colonic bacteria impairs digestion of food triggers, enhancing IgE-mediated immune responses.
  • Mast cell recruitment and activation in the colon mediate visceral pain and low-grade inflammation upon re-exposure to sensitizing foods.
  • In IBD patients, self-reported food intolerances correlate with microbial alterations and reduced food-metabolizing bacteria, suggesting translational relevance.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unveiling the Role of HtpG-High-Expressing Escherichia coli in Chronic Pancreatitis Fibrosis: Microbiota-Targeted Therapeutic HopeIdentification of a pathogenic E. coli strain overexpressing HtpG that promotes fibrosis in chronic pancreatitis via macrophage-mediated pathways highlights new microbiota-targeted treatment avenues.Oct 18, 2026Reevaluating Colorectal Cancer Surveillance in Inflammatory Bowel Disease: The Role of Family History Beyond Early-Onset CasesA nationwide cohort study reveals that in IBD patients, colorectal cancer risk increases notably with multiple affected relatives, challenging current guidelines prioritizing early-onset family history for surveillance.Sep 6, 2026Early Childhood Exposure to Crohn’s Disease-Affected Siblings: Implications for Gut Microbiome and Disease SusceptibilityChildhood exposure to siblings with Crohn’s disease significantly raises disease risk, linked to distinct gut microbiome changes that may drive disease onset through immune modulation.Aug 27, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Outcomes of Colorectal Dysplasia and Cancer in Patients with PSC-IBD Undergoing Liver Transplantation and Colectomy: Insights from a Multicenter Study
This multicenter retrospective study examines colorectal dysplasia and malignancy outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease undergoing liver transplantation and colectomy, revealing comparable 5
Jul 15, 2026
Impact of Acetaldehyde Metabolism on Alcohol-Related Inflammatory Bowel Disease Risk: A Precision Medicine PerspectiveThis study elucidates how genetic differences in acetaldehyde metabolism modify the risk of alcohol-associated inflammatory bowel disease (IBD), highlighting personalized prevention strategies.Jul 3, 2026
IBDome: Integrating Molecular, Histopathological, and Clinical Data to Transform Inflammatory Bowel Disease ManagementIBDome offers a comprehensive multiomic atlas integrating molecular, histopathological, and clinical data, advancing the understanding and precision treatment of Crohn’s disease and ulcerative colitis.Jul 3, 2026